S100A8 and S100A9 proteins upregulate the expression of proinflammatory cytokines such as IL-6 and IL-838–41; therefore, the HCQ-mediated modulation of S100 proteins may also be involved in the suppression of proinflammatory cytokine expression in SLE patients. Here, S100A9 is linked to systemic lupus erythematosus.